Adjuvante Therapie mit Olaparib bei BRCA1/2-assoziiertem Mammakarzinom

Laura Dussan Molinos; Natalia Krawczyk; Lars Hanker; Achim Rody; Maggie Banys-Paluchowski

doi:10.1007/s00761-022-01097-9

Adjuvante Therapie mit Olaparib bei BRCA1/2-assoziiertem Mammakarzinom

Translated title of the contribution: Adjuvant treatment with olaparib for BRCA1/2-associated breast cancer

Laura Dussan Molinos^*, Natalia Krawczyk, Lars Hanker, Achim Rody, Maggie Banys-Paluchowski

^*Corresponding author for this work

University of Düsseldorf

1 Citation (Scopus)

Translated title of the contribution	Adjuvant treatment with olaparib for BRCA1/2-associated breast cancer
Original language	German
Journal	Onkologe
Volume	28
Issue number	3
Pages (from-to)	244-247
Number of pages	4
ISSN	0947-8965
DOIs	https://doi.org/10.1007/s00761-022-01097-9
Publication status	Published - 03.2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Areas and Centers

Research Area: Luebeck Integrated Oncology Network (LION)
Centers: University Cancer Center Schleswig-Holstein (UCCSH)

DFG Research Classification Scheme

2.22-21 Gynaecology and Obstetrics
2.22-14 Hematology, Oncology

Access to Document

10.1007/s00761-022-01097-9

Cite this

@article{d193efd636f54192aaa4551333eb1862,

title = "Adjuvante Therapie mit Olaparib bei BRCA1/2-assoziiertem Mammakarzinom",

author = "\{Dussan Molinos\}, Laura and Natalia Krawczyk and Lars Hanker and Achim Rody and Maggie Banys-Paluchowski",

year = "2022",

month = mar,

doi = "10.1007/s00761-022-01097-9",

language = "Deutsch",

volume = "28",

pages = "244--247",

journal = "Onkologe",

issn = "0947-8965",

publisher = "Springer Medizin",

number = "3",

}

TY - JOUR

T1 - Adjuvante Therapie mit Olaparib bei BRCA1/2-assoziiertem Mammakarzinom

AU - Dussan Molinos, Laura

AU - Krawczyk, Natalia

AU - Hanker, Lars

AU - Rody, Achim

AU - Banys-Paluchowski, Maggie

PY - 2022/3

Y1 - 2022/3

UR - https://www.scopus.com/pages/publications/85124721190

UR - https://www.mendeley.com/catalogue/a5d79708-c95f-3644-9e39-e89daacc6471/

U2 - 10.1007/s00761-022-01097-9

DO - 10.1007/s00761-022-01097-9

M3 - Zeitschriftenaufsätze

AN - SCOPUS:85124721190

SN - 0947-8965

VL - 28

SP - 244

EP - 247

JO - Onkologe

JF - Onkologe

IS - 3

ER -

Adjuvante Therapie mit Olaparib bei BRCA1/2-assoziiertem Mammakarzinom

UN SDGs

Research Areas and Centers

DFG Research Classification Scheme

Access to Document

Other files and links

Cite this